Malaysian Genomics Resource (KLSE:0155) — Stock Price
Malaysian Genomics Resource (KLSE:0155) is currently trading at RM0.32 MYR, up 0.00% today. Over the past 52 weeks, shares have ranged between RM0.17 and RM0.32. This page tracks Malaysian Genomics Resource's live share price on the KLSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Malaysian Genomics Resource.
Malaysian Genomics Resource (0155) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Malaysian Genomics Resource's daily closing share price and trading volume on the KLSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Malaysian Genomics Resource Income Statement — Revenue, Profit & Earnings by Year
Malaysian Genomics Resource's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | RM8.02 Million | RM5.52 Million | RM12.86 Million | RM8.36 Million | RM28.36 Million |
| Cost of Revenue | RM2.88 Million | RM2.09 Million | RM5.36 Million | RM3.26 Million | RM14.51 Million |
| Gross Profit | RM5.14 Million | RM3.43 Million | RM7.50 Million | RM5.10 Million | RM13.85 Million |
| Research & Development | — | — | — | — | — |
| SG&A | RM5.87 Million | RM8.12 Million | RM29.95 Million | RM11.12 Million | RM7.83 Million |
| Total Operating Expenses | RM8.75 Million | RM9.92 Million | RM35.25 Million | RM12.48 Million | RM22.34 Million |
| Operating Income | RM-728.95K | RM-4.40 Million | RM-22.39 Million | RM-13.59 Million | RM6.28 Million |
| EBITDA | — | — | — | — | RM7.42 Million |
| EBIT | — | — | — | RM-13.55 Million | RM6.02 Million |
| Interest Expense | RM95.53K | RM119.18K | — | RM96.00K | RM102.00K |
| Income Before Tax | RM-2.49 Million | RM-4.51 Million | RM-22.54 Million | RM-13.59 Million | RM6.18 Million |
| Income Tax Expense | — | — | — | RM1.15 Million | RM-1.03 Million |
| Net Income | RM-2.38 Million | RM-4.19 Million | RM-21.51 Million | RM-14.25 Million | RM7.21 Million |
Malaysian Genomics Resource Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Malaysian Genomics Resource's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | RM18.71 Million | RM22.36 Million | RM25.70 Million | RM30.87 Million | RM41.89 Million |
| Total Current Assets | RM9.55 Million | RM11.59 Million | RM16.07 Million | RM21.43 Million | RM30.06 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | RM2.60 Million | RM10.15 Million | RM13.95 Million | RM19.16 Million | RM9.11 Million |
| Inventory | RM390.50K | RM936.53K | RM619.10K | RM435.00K | RM383.36K |
| Property, Plant & Equipment | — | RM4.39 Million | RM5.34 Million | RM4.94 Million | RM5.80 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | RM3.92 Million | RM4.20 Million | RM3.36 Million | RM4.08 Million | RM4.84 Million |
| Total Current Liabilities | RM3.00 Million | RM3.56 Million | RM2.01 Million | RM1.79 Million | RM1.66 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | RM15.77 Million | RM18.16 Million | RM22.35 Million | RM26.79 Million | RM37.05 Million |
| Retained Earnings | RM-1.66 Million | RM-41.28 Million | RM-37.09 Million | RM-29.82 Million | RM-15.57 Million |
Malaysian Genomics Resource Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Malaysian Genomics Resource generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | RM1.10 Million | RM-744.97K | RM-24.97 Million | RM-22.07 Million | RM56.92K |
| Capital Expenditures | RM71.64K | RM208.10K | RM596.52K | RM442.00K | RM1.33 Million |
| Free Cash Flow | RM1.03 Million | RM-953.07K | — | RM-21.21 Million | RM-1.27 Million |
| Investing Cash Flow | — | RM-178.53K | RM-530.52K | RM-381.00K | RM-2.44 Million |
| Financing Cash Flow | — | RM-228.96K | RM6.40 Million | RM3.62 Million | RM11.59 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | RM1.47 Million | RM1.15 Million | RM1.93 Million | RM1.74 Million | RM1.14 Million |
| Change in Cash | RM747.93K | RM-1.15 Million | RM-19.10 Million | RM-18.82 Million | RM9.21 Million |
Malaysian Genomics Resource Earnings History — EPS Actual vs. Analyst Estimates
Track Malaysian Genomics Resource's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 26, 2026 | 0.01 | — | — |
| Feb 27, 2026 | -0.01 | — | — |
| Nov 26, 2025 | 0.00 | — | — |
| Aug 27, 2025 | 0.00 | — | — |
| May 26, 2025 | -0.01 | — | — |
| Feb 27, 2025 | 0.00 | — | — |
| Nov 27, 2024 | -0.01 | — | — |
| Aug 28, 2024 | -0.01 | — | — |